How the NHS research governance procedures could be modified to greatly strengthen clinical research

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 10, Issue 2, 2010, Pages 127-129

  Haynes, Richard ^a   Bowman, Louise ^a   Rahimi, Kazem ^a   Armitage, Jane ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Clinical trials; Regulation; Research governance

Indexed keywords

CLINICAL DECISION MAKING; CLINICAL RESEARCH; GENERAL PRACTICE; GOLD STANDARD; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN RIGHTS; MEDICAL RECORD; NATIONAL HEALTH SERVICE; PROFESSIONAL STANDARD; SHORT SURVEY; UNITED KINGDOM;

EID: 77950591707     PISSN: 14702118     EISSN: 14734893     Source Type: Journal    
DOI: 10.7861/clinmedicine.10-2-127     Document Type: Short Survey

References (5)

1. Stewart PM, Stears A, Tomlinson JW, Brown MJ. Regulation - the real threat to clinical research. BMJ 2008;337:a1732.
2. Hackshaw A, Farrant H, Bulley S, Seckl MJ, Ledermann JA. Setting up non-commercial clinical trials takes too long in the UK: findings from a prospective study. J R Soc Med 2008;101:299-304.
3. Kielmann T, Tierney A, Porteous R et al. The Department of Health's research governance framework remains an impediment to multi-centre studies: findings from a national descriptive study. J R Soc Med 2007;100:234-238 (Pubitemid 46814779)
4. Sheard L, Tompkins CN, Wright NM, Adams CE. Non-commercial clinical trials of a medicinal product: can they survive the current process of research approvals in the UK? J Med Ethics 2006;32:430-434 (Pubitemid 44070013)
5. Al-Shahi Salman R, Brock TM, Dennis MS et al. Research governance impediments to clinical trials: a retrospective survey. J R Soc Med 2007;100:101-104